Photodynamic Therapy and ALA (ALA-PDT)

From Skin & Aging, Volume 13, Issue 3, March 2005, Pages: 42 – 51

The Ever-Increasing Role of ALA-PDT, Part 2

The topical application of 5-amino-levulinic acid (ALA) and exposure to a variety of lasers and light sources and photodynamic therapy (PDT), has become a very popular dermatologic procedure for a variety of clinical concerns affecting our patients. Presently, 20% 5-aminolevulinic acid (Levulan) is the only FDA-approved formulation.ALA-PDT is fast becoming a standard treatment for photorejuvenation with and without actinic keratoses (AKs), acne vulgaris, rosacea, sebaceous gland hyperplasia and hidradenitis suppurativa.

See also

• The Ever-Increasing Role of ALA-PDT, Part 1 of 2

Related Articles

• PDT shows promise for rosacea treatment
• be careful with Levulan (aminolevulinic acid)
• photodynamic therapy for rhinophyma

Read more about: PDT, laser therapy